Creo Medical Receives Equity Investment from Pentax Medical

Creo Medical Ltd., a Chepstow, United Kingdom-based electrosurgical energy devices company, received an equity investment from PENTAX Medical, a division of HOYA Group.

The investment, of undisclosed amount, will allow PENTAX Medical to expand their presence in the therapeutics segment through a lineup of differentiated products.

Founded in 2003 and led by Craig Gulliford, CEO, Creo Medical is a medical device company that engages in the development of microwave and radio frequency technology systems that are used in the treatment of tissue resection, ablation, and coagulation.
Products include CRoMa, a microwave and bipolar radiofrequency energy system for the treatment of tissue effects.



Join the discussion